Sandbox drugchapter: Difference between revisions

Latest revision as of 06:50, 10 February 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Adapted from the FDA Package Insert.

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Rizatriptan}}
+{{XXXXX}}
 {{CMG}}
-==
+==Title==
-<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d93286f5-99f7-4dc5-aa9d-ad73ab8490db | publisher =  | date =  | accessdate = }}</ref>
 ==References==
@@ Line 12: / Line 14: @@
 {{FDA}}
-[[Category:Antimigraine drugs]]
+[[Category:Cardiovascular Drugs]]
 [[Category:Drugs]]
-[[Category:Triptans]]